A new research paper was published in Oncotarget’s Volume 15 on February 5, 2024, entitled, «Differential expression of Mad2 gene is consequential to the patterns of histone H3 post-translational modifications in its promoter region in human esophageal cancer samples.»
Mad2 expression levels with chromosomal abnormalities can be a biomarker for esophageal cancer
A new research paper was published in Oncotarget's Volume 15 on February 5, 2024, entitled, "Differential expression of Mad2 gene is consequential to the patterns of histone H3 post-translational modifications in its promoter region in human esophageal cancer samples."